| Dr Steven John White, MD | |
|
8230 Walnut Hill Ln Ste 814, Dallas, TX 75231-4485 | |
| (214) 696-6676 | |
| (214) 696-1477 |
| Full Name | Dr Steven John White |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 8230 Walnut Hill Ln Ste 814, Dallas, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295027548 | NPI | - | NPPES |
| 00266G TX | Other | MEDICARE | |
| G31824 TX | Other | UPIN | |
| TPI 0299232-01 TX | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | H6703 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven John White, MD 8230 Walnut Hill Ln Ste 814, Dallas, TX 75231-4485 Ph: (214) 696-6676 | Dr Steven John White, MD 8230 Walnut Hill Ln Ste 814, Dallas, TX 75231-4485 Ph: (214) 696-6676 |
News Archive
Cocaine use has increased substantially among African Americans in some of the most underserved areas of the United States. Interventions designed to increase connection to and support from non-drug using family and friends, with access to employment, the faith community, and education, are the best ways to reduce substance use among African Americans and other minorities in low-income, resource-poor communities, concludes a study led by a medical anthropologist at the University of California, Riverside.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.
Scientists at the University of Kentucky have discovered that plasminogen, a protein used by the body to break up blood clots, speeds up the progress of prion diseases such as mad cow disease.
New research findings published in the Journal of Leukocyte Biology, suggest that treating the white blood cells of sepsis patients with antibodies that block programmed cell death-1 (PD-1) and programmed cell death ligand (PD-L1) molecules may restore their function and ultimately their ability to eradicate deadly bacteria.
› Verified 5 days ago
Bryan Stapp Armijo, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9101 N Central Expy Ste 600, Dallas, TX 75231 Phone: 214-540-1434 Fax: 469-375-3823 | |
Raja Mohan, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7777 Forest Ln Ste C820, Dallas, TX 75230 Phone: 469-301-1725 Fax: 469-301-1769 | |
Danielle Cooper, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 17311 Dallas Pkwy Ste 100, Dallas, TX 75248 Phone: 214-540-0371 | |
Dr. Neil A Mauskar, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3409 Worth St Ste 600, Dallas, TX 75246 Phone: 972-817-6170 Fax: 972-817-6180 | |
Dr. Jessica Isabelle Billig, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 142-645-2353 Fax: 142-645-3163 | |
Jessica Theresa Goodwin, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3500 Gaston Ave, Dallas, TX 75246 Phone: 214-820-2361 | |
Patrick Lynn Hodges, Plastic Surgery Medicare: Medicare Enrolled Practice Location: 8220 Walnut Hill Ln, Suite 206, Dallas, TX 75231 Phone: 214-739-5760 |